Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
sCiEnTiFiC proGrAMME<br />
Friday 11 May 2012<br />
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung<br />
Page 146 PROgRammE & ExhibiTiOn guidE • ESTRO 31<br />
abS. numbER<br />
17:05 > Planned dose, expected dose and delivered dose:<br />
The benefit of probabilistic population based plan evaluation<br />
T. Janssen (The Netherlands), R. Bohoslavsky, S. van Kranen,<br />
E. Damen, M. van Herk, C. van Vliet-Vroegindeweij, M. Witte OC-0380<br />
DEBATE<br />
wE shoUld do prE-TrEATMEnT QA For iMrT EVEn ThoUGh wE didn’T do<br />
iT For ConForMAl ThErApy<br />
lEaRning ObJECTivES:<br />
1. Advanced technology requires advanced QA and verification. The question is how<br />
best to do this in resource-limited scenarios<br />
2. Cost-balance arguments around pre-treatment QA (and towards 2D/3D IVBD)<br />
3. Efficient methods, automated, integrated methods are necessary (professional<br />
community message to manufacturers)<br />
16:15 - 17:15 • Room 116<br />
ChaiR: D.I. Thwaites (United Kingdom)<br />
CO-ChaiR: A. Garcia-Romero (Spain)<br />
16:15 > For the motion - Pre-treatment, patient-specific QA is<br />
essential to ensure quality and safety<br />
SPEaKER: T. Pawlicki (USA) SP-0381<br />
16:35 > Against the motion<br />
SPEaKER: H. Nyström (Sweden) SP-0382<br />
PROFFERED PAPERS<br />
rAdiobioloGy 3: TUMoUr MiCroEnVironMEnT<br />
16:15 - 17:15 • Room 120-121<br />
ChaiR: J. Alsner (Denmark)<br />
CO-ChaiR: M. Krause (Germany)<br />
16:15 > Micro and messenger RNAs involved in hypoxia sensitivity<br />
in head and neck squamous cell carcinoma<br />
P. Span (The Netherlands), M. Bussink, J. Bussink, J.H. Kaanders OC-0383<br />
Friday 11 May 2012<br />
abS. numbER<br />
16:25 > Hypoxia-inducible factor 1a and 2a in whole-mount prostate<br />
histology: independent of DCE-MRI<br />
A. Borren (The Netherlands), G. Groenendaal, M.R. Moman,<br />
A.E. Boeken Kruger, P. van der Groep, P.J. van Diest,<br />
U.A. van der Heide, M. van Vulpen, M.E.P. Philippens OC-0384<br />
16:35 > Pancreatic stellate cells induce EMT concurrent with an increase<br />
in cancer stem-like cells and radioresistance<br />
O. Al-Assar (United Kingdom), F. Demircioglu, S. Lunardi,<br />
T. Brunner OC-0385<br />
16:45 > Nitric oxide-producing hepatocytes radiosensitize hypoxic<br />
colorectal cancer cells through oxygen sparing<br />
H. Jiang (Belgium), V. Verovski, K. Law, M. Vermeersch,<br />
G. Storme, D. Van den Berge, T. Gevaert, D. Verellen,<br />
M. De Ridder OC-0386<br />
16:55 > Multiparametric MRI imaging in patients undergoing<br />
ultra-hypofractionated RT for localised prostate cancer<br />
K. Yip (United Kingdom), J. Taylor, P. Hoskin, N. Shah, P. Ostler,<br />
I. Simcock, J. Stirling, D. Collins, A. Padhani, R. Alonzi OC-0387<br />
17:05 > HIF pathway inhibition resolves tumour hypoxia and improves<br />
local tumour control after irradiation<br />
L. Helbig (Germany), H. Galleiske, L. Koi, K. Brüchner,<br />
A. Yaromina, M. Baumann, D. Zips OC-0388<br />
PROFFERED PAPERS<br />
rTT 3: VolUME dEFiniTion, TrEATMEnT MArGins And GEoMETriC<br />
UnCErTAinTiEs<br />
16:15 - 17:15 • Room 118-119<br />
ChaiR: F. Cellini (Italy)<br />
CO-ChaiR: A. Gomez-Iturriaga (Spain)<br />
16:15 > An investigation of the dosimetric implications of contouring<br />
variability in 3DCRT of the prostate<br />
C. Rogerson (Ireland Republic of), M. Leech OC-0389<br />
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 147<br />
sCiEnTiFiC proGrAMME<br />
eSTRO 31
Change language